Josep Tabernero Caturla
Dades destacades
- Última publicació:A path to translation: How 3D patient tumor avatars enable next generation precision oncology.
Dades del professional
Hospital Universitari Quirónsalud Barcelona
CAP DE SERVEI
Febrer 2018
Estudi
Doctor en medicina
universitat, Universitat Autònoma de Barcelona
Doctorat
Universitat Autònoma de Barcelona
Formació Sanitària Especialitzada
Oncologia Mèdica
hospital
Estudis de fase I i II amb nous agents
Investigació de fàrmacs per al càncer colorectal
Estudi de biomarcadors circulants
Desenvolupament de nous models de xenoempelts
Desenvolupament de Cetuximab i Panitunumab
A path to translation: How 3D patient tumor avatars enable next generation precision oncology.
Journal Article
Clinical management of metastatic colorectal cancer in the era of precision medicine.
Journal Article, Review
Efficacy of Pembrolizumab Monotherapy for Advanced Gastric/Gastroesophageal Junction Cancer with Programmed Death Ligand 1 Combined Positive Score =10.
Journal Article
Enhancing global access to cancer medicines.
Journal Article, Review
HERIZON-GEA-01: Zanidatamab + chemo ± tislelizumab for 1L treatment of HER2-positive gastroesophageal adenocarcinoma.
Journal Article, Review
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Practice Guideline
Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines.
Journal Article, Research Support, Non-U.S. Govt, Review
Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials.
Journal Article
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study.
Journal Article
Population pharmacokinetics and covariate analysis of Sym004, an antibody mixture against the epidermal growth factor receptor, in subjects with metastatic colorectal cancer and other solid tumors.
Journal Article, Research Support, Non-U.S. Govt
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA.
Journal Article, Review
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score.
Journal Article, Multicenter Study, Research Support, Non-U.S. Govt
Trifluridine/tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
Journal Article, Randomized Controlled Trial, Clinical Trial, Phase III, Multicenter Study
Trifluridine/tipiracil plus bevacizumab for third-line management of metastatic colorectal cancer: SUNLIGHT study design.
Journal Article
Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study.
Journal Article
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer.
Journal Article
Demana cita amb aquest professional
Articles de
Consulta els darrers articles a Tu canal de salud.
Últimes col·laboracions en tucanaldesalud.es Josep Tabernero Caturla
Articles, entrevistes o vídeos en què ha col·laborat
- Canal ciencia
Los últimos avances en Oncología (HOPE)
Los cambios en la forma de diagnosticar y tratar, la estrecha unión entre investigación y atención médica, los nuevos fármacos… han dado un vuelco a la Oncología
Vídeos de
Consulta el contenido multimedia de este profesional.
Àrea personal de salut: Mi Quirónsalud
Accedeix a qualsevol hora del dia per tenir cura de la teva salut i la dels teus.
Mi Quirónsalud és el teu espai personal privat i segur, on pots sol·licitar i gestionar les teves cites o consultar els teus informes clínics sense esperes ni desplaçaments.
Descobreix-ho!